Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab

Gondry, O. (Speaker), Özdemir, I. (Contributor), Jansen, Y. (Contributor), Awada, G. (Contributor), Schwarze, J. K. (Contributor), Teofila Seremet (Contributor), Everaert, H. (Contributor), Neyns, B. (Contributor), Keyaerts, M. (Contributor)

Activity: Talk or presentationTalk or presentation at a workshop/seminar

Description

Oral presentation
Period19 Oct 2018
Event titleORC day 2018
Event typeConference
LocationJette, Belgium
Degree of RecognitionLocal